Peak Serum: Implications of Serum Supply for Cell Therapy Manufacturing
David Brindley(Orbus Therapeutics (United States)), Jon A. Rowley(University of Michigan–Ann Arbor), Emily J Culme-Seymour(GlaxoSmithKline (United Kingdom)), Natasha L. Davie(Harvard University), David Smith(Loughborough University), Chris Mason(Oak Ridge National Laboratory)
Cited by 144
Related Papers
A Brief Definition of Regenerative Medicine
|Regenerative Medicine|2007|795
BTRFS
|ACM Transactions on Storage|2013|381
Lancet Commission: Stem cells and regenerative medicine
|The Lancet|2017|276
Cell Therapy Industry: Billion Dollar Global Business with Unlimited Potential
|Regenerative Medicine|2011|144
Biochemical changes caused by decellularization may compromise mechanical integrity of tracheal scaffolds
|Acta Biomaterialia|2012|125